Syndax Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 8.24 M | $173.10 M | -4.48% | 9.51% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 8.05 M | $169.15 M | -5.51% | 9.29% |
| VANGUARD GROUP INC | 01/29/2026 | 6.23 M | $130.90 M | 21.25% | 7.19% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 5.70 M | $119.66 M | 3.81% | 6.58% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 4.88 M | $102.57 M | 14.74% | 5.64% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 4.71 M | $98.97 M | 27.39% | 5.44% |
| STATE STREET CORP | 02/13/2026 | 4.60 M | $96.57 M | 19.28% | 5.31% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 3.31 M | $69.64 M | -4.41% | 3.83% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.42 M | $50.88 M | 1.30% | 2.80% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/17/2026 | 2.35 M | $49.37 M | -6.00% | 2.71% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.32 M | $48.67 M | 100.00% | 2.67% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 2.25 M | $47.21 M | 11.68% | 2.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.09 M | $43.94 M | -0.02% | 2.41% |
| 02/17/2026 | 1.86 M | $38.97 M | 100.00% | 2.14% | |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 1.60 M | $33.59 M | 97.58% | 1.85% |
| NUVEEN, LLC | 02/12/2026 | 1.48 M | $31.16 M | 0.49% | 1.71% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.38 M | $28.90 M | 11.29% | 1.59% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 1.34 M | $28.14 M | -1.96% | 1.55% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.34 M | $28.11 M | -2.76% | 1.54% |
| AISLING CAPITAL MANAGEMENT LP | 02/10/2026 | 1.32 M | $27.67 M | 0.00% | 1.52% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.25 M | $26.28 M | -19.34% | 1.44% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 1.24 M | $26.01 M | 25.26% | 1.43% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.22 M | $25.62 M | 13.18% | 1.41% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.20 M | $25.14 M | -25.88% | 1.38% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.15 M | $24.10 M | 60.94% | 1.32% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 1.09 M | $22.99 M | 3.97% | 1.26% |
| MORGAN STANLEY | 02/13/2026 | 1.08 M | $22.60 M | -10.32% | 1.24% |
| ALGERT GLOBAL LLC | 02/17/2026 | 928.09 K | $19.50 M | -0.29% | 1.07% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 925.97 K | $19.45 M | 65.92% | 1.07% |
| CANDRIAM S.C.A. | 04/30/2026 | 925.33 K | $19.44 M | 0.00% | 1.07% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 794.51 K | $16.69 M | 21.31% | 0.92% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 762.56 K | $16.02 M | 96.68% | 0.88% |
| JANE STREET GROUP, LLC | 02/12/2026 | 748.92 K | $15.73 M | 1.44% | 0.86% |
| NORTHERN TRUST CORP | 02/17/2026 | 728.92 K | $15.31 M | -6.15% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 727.42 K | $15.28 M | 1.17% | 0.84% |
| APIS CAPITAL ADVISORS, LLC | 02/17/2026 | 724.00 K | $15.21 M | 13.48% | 0.84% |
| UBS GROUP AG | 01/29/2026 | 716.22 K | $15.05 M | -57.23% | 0.83% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 688.14 K | $14.46 M | -58.16% | 0.79% |
| PROSIGHT MANAGEMENT, LP | 02/13/2026 | 665.00 K | $13.97 M | -33.73% | 0.77% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 642.90 K | $13.51 M | 38.64% | 0.74% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 632.75 K | $13.29 M | 65.19% | 0.73% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 574.02 K | $12.06 M | -32.22% | 0.66% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 554.76 K | $11.66 M | 665.57% | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 544.80 K | $11.45 M | -36.69% | 0.63% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 02/17/2026 | 515.13 K | $10.82 M | 313.51% | 0.59% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 487.00 K | $10.23 M | -15.16% | 0.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 434.10 K | $9.12 M | 5.11% | 0.50% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 424.50 K | $8.92 M | -31.40% | 0.49% |
| KNOTT DAVID M JR | 02/12/2026 | 415.00 K | $8.72 M | -3.04% | 0.48% |
| JPMORGAN CHASE & CO | 02/11/2026 | 378.50 K | $7.95 M | 49.11% | 0.44% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syndax Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 305 institutional investors and hedge funds held shares of Syndax Pharmaceuticals Inc. The most heavily invested institutionals were:
Nuveen, LLC: 1.49 M
Aisling Capital Management LP: 1.32 M
UBS Group AG: 1.15 M
Bank of New York Mellon Corp: 1 M
Candriam S.C.A.: 925,332
abrdn plc: 286,969
115.33% of Syndax Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 111.65 M shares in the last 24 months. This purchase volume represents approximately $2.67 B in transactions.